Morbidity of chronic hepatitis C as seen in a tertiary care medical center

Digestive Diseases and Sciences

Volumn 42, Issue 1, 1997, Pages 186-191

  Lee, David H ^a   Jamal, Hyder ^a   Regenstein, Fredric G ^a   Perrillo, Robert P ^a,b  

^a OCHSNER MEDICAL CENTER   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

hepatitis C; morbidity

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEALTH CARE; HEPATITIS C; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORBIDITY; PRIORITY JOURNAL;

ADULT; CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 0031020755     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018818012378     Document Type: Article

References (19)

1. Dienstag JL: Non-A, non-B hepatitis: I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439-462, 1983
2. Seeff LB, Buskell-Bales Z, Wright EC, et al: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906-1911, 1992
3. Alter HJ: Chronic consequences of non-A, non-B hepatitis. In LB Seeff, JH Lewis, (eds). New York, Plenum Medical, 1989, pp 83-97
4. Di Bisceglie AM, Goodman ZD, Ishak KG, et al: Long-term clinical and histological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969-974, 1991
5. Realdi G, Alberti A, Rugge M, et al: Long-term follow-up of acute and chronic non-A, non-B hepatitis: Evidence of progression to liver cirrhosis. Gut 23:270-275, 1982
6. Koretz RL, Abbey H, Coleman E, et al: Non-A, non-B post-transfusion hepatitis: Looking back in the second decade. Ann Intern Med 119:110-115, 1993
7. Davis GL, Balart LA, Schiff ER, et al: Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clin Ther 16:334-343, 1994
8. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al: Hepatitis C virus genotypes: An investigation of type-specific difference in geographic origin and disease. Hepatology 19:13-18, 1994
9. Yoshioka K, Kakumu S, Wakita T, et al: Detection of hepatitis C virus by polymerase chain reaction and response to interferon alfa therapy: Relationship to genotypes of hepatitis C virus. Hepatology 16:293-299, 1992
10. Mendenhall C, Seeff L, Diehl AM, et al: Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis. Their prevalence and clinical relevance. Hepatology 14:581-589, 1991
11. Caldwell SH, Li X, Rourk RM, et al: Hepatitis C infection by polymerase chain reaction in alcoholics: False-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastgroenterol 88:1016-1021, 1993
12. Davis GL, Balart LA, Schiff ER, et al: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter, randomized, controlled trial. N Engl J Med 321:1501-1506, 1989
13. Pawlotsky JM, Ben Yahia M, Andre C, et al: Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology 19:841-848, 1994
14. Lunel F, Musset L, Cacoub P, et al: Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300, 1994
15. Fargion S, Piperno A, Cappellini MD, et al: Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16:1322-1326, 1992
16. Rebora A, Robert E, Rongioletti F: Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci 4:38-41, 1992
17. Gray H, Wreghitt T, Stratton IM, et al: High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 12:244-249, 1995
18. Mason A, Lau JYN, Qian KP, et al: Association of diabetes mellitus with chronic hepatitis C virus (HCV) infection. Hepatology 22:351A, 1995 (abstract)
19. Taruschio G, Santarini F, Sica G, et al: Psychiatric disorders in hepatitis C virus related chronic liver disease. Gastroenterology 110:A1342, 1996 (abstract)